You are here: Industry Insights > Bayer

News List

111, Inc. Teams Up with Bayer Healthcare to Explore the Vast Blue Ocean of Online Healthcare prnasia
October 22, 2020
On September 24, 111, Inc. entered into a strategic partnership with Bayer Healthcare Co. Ltd. The two companies will collaborate on drug commercialization initiatives in China, including the commercialization of innovative drugs and healthcare products..
Recursion raises $239m and signs drug discovery deal with Bayer pharmaceutical-technology
September 24, 2020
Digital biology company Recursion Pharmaceuticals has secured $239m in a Series D financing round led by Leaps by Bayer, the impact investment arm of Bayer.
Bayer gets DCGI nod for intravitreal aflibercept injection, Eylea to treat diabetic macular edema expresspharma
September 23, 2020
Intravitreal Aflibercept is administered via injection directly in the area of swelling in the eye.
Bayer’s Adempas meets primary endpoint in phase 4 trial in PAH patients pharmaceutical-business-review
September 23, 2020
Bayer said that the phase 4 REPLACE trial evaluating Adempas (riociguat) in intermediate-risk adult patients with pulmonary arterial hypertension (PAH) has met its primary endpoint.
Bayer’s Vitrakvi shows long-term efficacy in TRK fusion-positive cancers pharmatimes
September 21, 2020
Bayer’s tumour agnostic therapy Vitrakvi has demonstrated sustained, long-term efficacy and safety in a number of tropomyosin receptor kinase (TRK) fusion-positive cancers, including lung and thyroid tumours.
Bayer, Recursion Collaborate on Therapies for Fibrotic Diseases americanpharmaceuticalreview
September 16, 2020
Bayer and US-based Recursion Pharmaceuticals have entered into a strategic collaboration agreement.
Bayer invests in cancer therapies developer Triumvira Immunologics pharmaceutical-technology
August 31, 2020
Bayer’s investment unit Leaps by Bayer and Northpond Ventures led the $55m Series A funding round of cancer therapies developer Triumvira Immunologics.
Bayer and Informed Data Systems Inc. (One Drop) join forces to jointly develop digital health products across therapeutic areas worldpharmanews
August 25, 2020
Bayer and Informed Data Systems Inc. (One Drop), a US-based digital health company, announced that they have entered into an agreement to jointly develop digital health products for multiple therapeutic areas.
Bayer to acquire KaNDy Therapeutics with $425 million upfront payment europeanpharmaceuticalreview
August 17, 2020
Bayer will acquire KaNDy Therapeutics Ltd for an upfront cost of $425 million to expand its drug development pipeline in women’s healthcare.
Advent Life Sciences announces sale of KaNDy Therapeutics to Bayer expresspharma
August 13, 2020
The sale is for $425 million upfront plus potential milestone payments of up to $425 million followed by further potential commercial milestones.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page